Clinical Trial Update: Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating mesenchymal stem cells for the treatment of amyotrophic lateral sclerosis (ALS) has completed, as reported by Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED